Skip to content
Claire M. Coeshott

Claire M. Coeshott, PhD, serves as the Director of the Immunology Laboratory for National Jewish Health Advanced Diagnostic Laboratories.



1978 - 1982
University of Bristol, Bristol, UK, PhD, Immunology
1975 - 1978
University of Bristol, Bristol, UK, BSc Cell Pathology


Coeshott, C., Vang, B., Jones, M., and Nankervis, B. Large-scale Expansion and Characterization of CD3+ T-cells in the Quantum Cell Expansion System. J Transl Med. 2019 Aug 7;17(1):258.

Cohn, A., Morse, M.A., O'Neil, B., Whiting, S., Coeshott, C., Ferraro, J., Bellgrau, D., Apelian, D. and Rodell, T.C. Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients with Solid Tumors Bearing Ras Mutations: Results from a Phase 1 Trial. J. Immunotherapy 41: 141-150, 2018. 

Gaggar, A., Coeshott, C., Apelian, D., Rodell, T., Shen, G., Subramanian, G. M. and McHutchinson, J.G. Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study. Vaccine 32: 4925-4931, 2014. 

Stubbs, A.C., Martin, K.S., Coeshott, C., Skaates, S.V., Kuritzkes, D.R., Bellgrau, D., Franzusoff, A., Duke, R.C. and Wilson, C.C. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nature Medicine 7:625-629, 2001.  

Coeshott, C., Ohnemus, C., Pilyavskaya, A., Ross, S.E., Wieczorek, M. Kroona, H., Leimer, A. and Cheronis, J. Converting enzyme-independent release of TNFα and IL-1β from stimulated THP-1, a human monocytic cell line, in the presence of activated neutrophils or purified proteinase 3. Proc. Natl. Acad. Sci. USA, 96: 6261-6266, 1999.

Conflicts of Interest

National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.